JPRN-jRCT2071260025 clinical trial report covering Cenobamate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07581951 clinical trial report covering HSK-31679, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Bevacizumab, an antibody targeting VEGF-A.

NCT07582315 clinical trial report covering Izalontamab Brengitecan, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07579351 clinical trial report covering Dexamethasone Sodium Phosphate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20261878 clinical trial report covering Recombinant Zoster Vaccine(CHO Cell)(Kangtai), Phase 3, endpoints, sponsor, geography, readout timing and developme

CTR20261818 clinical trial report covering C-019199, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07584525 clinical trial report covering Dexamethasone, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07582549 clinical trial report covering Amoxicillin Trihydrate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07583849 clinical trial report covering HSK-39004, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20261797 clinical trial report covering Citric Acid/Urea C-13, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07585266 clinical trial report covering Velzatinib, Phase 3, endpoints, sponsor, geography, readout timing and development white space.